Oocyte rescue in-vitro maturation does not adversely affect chromosome segregation during the first meiotic division.

Cumulus cells Euploidy In-vitro maturation Meiosis Oocyte Oocyte donor

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 23 05 2023
revised: 07 08 2023
accepted: 29 08 2023
medline: 3 11 2023
pubmed: 3 11 2023
entrez: 2 11 2023
Statut: aheadofprint

Résumé

Does rescue in-vitro maturation (IVM) in the presence or absence of cumulus cells, affect the progress of meiosis I, compared with oocytes that mature in vivo? This prospective study was conducted in a university-affiliated fertility centre. Ninety-five young oocyte donors (mean age 25.57 ± 4.47) with a normal karyotype and no known fertility problems were included. A total of 390 oocytes (116 mature metaphase II [MII] and 274 immature oocytes) were analysed. The immature oocytes underwent rescue IVM in the presence of cumulus cells (CC; IVM+CC; n = 137) or without them (IVM-CC; n = 137), and IVM rate was calculated. Chromosome copy number analysis using next-generation sequencing (NGS) was performed on all rescue IVM oocytes reaching MII as well as those that were mature at the time of initial denudation (in-vivo-matured oocytes [IVO]). Maturation rates were similar in IVM+CC and IVM-CC oocytes (62.8 versus 71.5%, P = 0.16). Conclusive cytogenetic results were obtained from 65 MII oocytes from the IVM+CC group, 87 from the IVM-CC group, and 99 from the IVO group. Oocyte euploidy rates for the three groups were similar, at 75.4%, 83.9% and 80.8%, respectively (P = 0.42). The results suggest that culture of germinal vesicle and metaphase I oocytes in the presence of cumulus cells does not improve rates of IVM. In general, the process of rescue IVM does not appear to alter the frequency of oocytes with a normal chromosome copy number.

Identifiants

pubmed: 37919136
pii: S1472-6483(23)00478-9
doi: 10.1016/j.rbmo.2023.103379
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103379

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Marga Esbert (M)

IVIRMA Global Research Alliance, IVI Barcelona, Barcelona, Spain. Electronic address: marga.esbert@ivirma.com.

Cristina García (C)

IVIRMA Global Research Alliance, IVI Barcelona, Barcelona, Spain.

Georgina Cutts (G)

Juno Genetics, Oxford Science Park, Oxford, UK.

Evelin Lara-Molina (E)

IVIRMA Global Research Alliance, IVI Barcelona, Barcelona, Spain.

Nicolás Garrido (N)

IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Agustín Ballestros (A)

IVIRMA Global Research Alliance, IVI Barcelona, Barcelona, Spain.

Richard T Scott (RT)

IVIRMA Global Research Alliance, RMA New Jersey, NJ, USA; Department of Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Emre Seli (E)

IVIRMA Global Research Alliance, RMA New Jersey, NJ, USA; Department of obstetrics, gynecology and reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.

Dagan Wells (D)

Juno Genetics, Oxford Science Park, Oxford, UK; Nuffield Department of Women's and Reproductive Health, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Classifications MeSH